Sanofi-aventis' Multaq
- Cardio
- 30/11/2009
This approval follows the European Commission positive opinion issued on September 25, 2009 by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicine agency (EMEA)....
READ MOREThis approval follows the European Commission positive opinion issued on September 25, 2009 by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicine agency (EMEA)....
READ MORERhesus Healthcare is pleased to announce it has formed a Joint Venture company with 3F Medical Systems. The new company is called Rhesus-3F Medical Systems and will focus on developing, manufa
READ MOREThe first-of-its kind device is currently under review by the U.S. Food and Drug Administration (FDA) for approval of a humanitarian device exemption (HDE), based on evidence of safety and probabl
READ MOREAccording to the agency, the inspection, which took place from Jan. 21 through March 10, revealed that devices, such as patient monitoring cardiac care products and ultrasound transducers, are...
READ MOREThe company reported increased global cardiac rhythm management (CRM) product sales of 8 percent
READ MOREAlready a world leader in radiology information systems (RIS) and picture archiving and communication systems (PACS) for medical images generated, for example, in radiology and cardiology departme
READ MOREThe CHMP has recommended the approval of Multaq
READ MOREAlso known as "e-cigarettes," electronic cigarettes are battery-operated devices designed to look like and to be used in the same manner as conventional cigarettes. The devices generally contain...
READ MOREThis year, there will be an Arrhythmia Alliance Patients' Day, Sunday 18th October, dedicated solely to all those who wish to learn more about their condition from leading international medical...
READ MOREXIENCE PRIME, which received CE Mark (Conformit
READ MORE